Lisata Therapeutics Completes Enrollment for Cancer Therapy Trial
By Karen Roman Biopharma company Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it finished patient enrollment...
By Karen Roman Biopharma company Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it finished patient enrollment...
By Karen Roman ReAlta Life Sciences said it is presenting new data at the American...
By Daniella Nanox (Nasdaq: NNOX), received FDA clearance to produce tomographic images for broader diagnostic...
By Karen Roman OmniScience and INmune Bio, Inc. (Nasdaq: INMB) said they’re using genAI in...
By Karen Roman Agendia, Inc. said its gene expression profiling test MammaPrint can predict...
PE Edge and Exec Edge are pleased to provide complete video coverage of the fourth...
PE Edge and Exec Edge are pleased to provide complete video coverage of the fourth...
Tech Edge and Exec Edge are pleased to provide complete video coverage of the fourth...
PE Edge and Exec Edge are pleased to provide complete video coverage of the fourth...
PE Edge and Exec Edge are pleased to provide complete video coverage of the fourth...